Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress

Journal of Psychosomatic Research

Volumn 53, Issue 4, 2002, Pages 865-871

  Tsigos, Constantine ^a,c   Chrousos, George P ^b,c  

^a Hellenic National Diabetes Center   (Greece)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Corticotropin releasing hormone or factor (CRH or CRF); Glucocorticoids; Stress

Indexed keywords

ARGININE; BETA ENDORPHIN; CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; FOLLITROPIN; GLUCOCORTICOID; GONADOTROPIN; GROWTH HORMONE; INSULIN; LIOTHYRONINE; LUTEINIZING HORMONE; NORADRENALIN; SEX HORMONE; SOMATOSTATIN; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; VASOPRESSIN;

ADAPTATION; ADIPOSE TISSUE; AMYGDALOID NUCLEUS; ANALGESIA; ANTICIPATION; ANXIETY; APPETITE; AROUSAL; ATTENTION; AUTONOMIC NERVOUS SYSTEM; CONFERENCE PAPER; DEPRESSION; DYSLIPIDEMIA; FATIGUE; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LOCUS CERULEUS; MELANCHOLIA; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROENDOCRINE SYSTEM; NOCICEPTION; OSTEOPOROSIS; PATHOLOGY; REWARD; STIMULATION; STRESS; SURVIVAL; SYMPTOMATOLOGY; THERMOGENESIS;

AUTONOMIC NERVOUS SYSTEM; CORTICOTROPIN-RELEASING HORMONE; FEEDBACK, BIOCHEMICAL; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STRESS;

EID: 0036805791     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(02)00429-4     Document Type: Conference Paper

References (47)

1. Chrousos GP, Gold PW. The concepts of stress system disorders: overview of behavioral and physical homeostasis. JAMA, J Am Med Assoc 1992;267:1244-52.
2. Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis: the corticotropin releasing hormone perspective. Endocrinol Metab Clinics NA 1992;21:833-58.
3. Tsigos C, Chrousos GP. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol Metab Clin North Am 1994;23:451-66.
4. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936;138:32-6.
5. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson A, Schulkin J, Contoreggi C, Chrousos G, McCann SM, Suomi SJ, Higley JD, Gold PW. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 2000;97:6079-84.
6. Gold PW, Goodwin F, Chrousos GP. Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress. Part 1. N Engl J Med 1988;319:348-53.
7. Gold PW, Goodwin F, Chrousos GP. Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress. Part 2. N Engl J Med 1988;319:413-20.
8. Habib KE, Gold PW, Chrousos GP. Neuroendocrinology of stress. Endocrinol Metab Clin North Am 2001;30:695-728.
9. Gray TS. Amygdala: role in autonomic and neuroendocrine responses to stress. In: McCubbin A, Kaufman PG, Nemeroff CB, editors. Stress, neuropeptides and systemic disease. New York: Academic Press, 1989. pp. 37-53.
10. Roth RH, Tam SY, Ida Y, Yang J, Deutch AY. Stress and the mesocorticolimbic dopamine systems. Ann NY Acad Sci 1988;537:138-47.
11. Nikalarakis KE, Almeida OFX, Herz A. Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor. Brain Res 1986;399:152-5.
12. Vale WW, Spiess S, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981;213:1394-7.
13. Lamberts SWJ, Verleun T, Oosterom R, DeJong P, Hackeng WHL. Corticotropin releasing factor and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 1984;58:298-303.
14. Engler O, Pham T, Fullenon MJ, Ooi G, Funder JW, Clarke IJ. Studies of the secretion of corticotropin releasing factor and arginine vasopressin into hypophyseal portal circulation of the conscious sheep. Neuroendocrinology 1989;49:367-81.
15. Horrocks PM, Jones AF, Ratcliffe WA, Holder G, White A, Holder R, Ratcliffe JG, London DR. Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females. Clin Endocrinol 1990;32:127-34.
16. Chrousos GP, Gold PW. A healthy body in a healthy mind - and vice versa - the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 1998;83:1842-5.
17. Holmes MC, Antoni FA, Aguilera G, Catt KJ. Magnocellular axons in passage through the median eminence release vasopressin. Nature 1986;319:126-9.
18. Phillips MI. Functions of angiotensin II the central nervous system. Ann Rev Physiol 1987;49:313-35.
19. Hinson JP. Paracrine control of adrenocortical function: a new role for the medulla? J Endocrinol 1990;124:7-9.
20. Ottenweller JE, Meier AH. Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology 1982;111:1334-8.
21. de Kloet RE. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991;12:95-164.
22. Smith DF, Toft DO. Steroid receptors and their associated proteins. Mol Endocrinol 1993;7:4-11.27.
23. Pratt WB. Glucocorticoid receptor structure and the initial events in signal transduction. Prog Clin Biol Res 1990;322:119-32.
24. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. Characterization of mechanisms involved in transrepression of NF-KB by activated glucocorticoid receptors. Mol Cell Biol 1995;15:943-53.
25. Gilbey P, Spyer P. Essential organization of the sympathetic nervous system. Bailliere's Clin Endocrinol Metab. 1993;7:259-2788;319:413-20.
26. Benarroch E.E. Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications. Ann Neurol 1994;36:6-13.
27. Elfvin L.-G. Lindh B, Hokfelt T. The chemical neuroanatomy of sympathetic ganglia. Ann Rev Neurosci 1993;16:471-507.
28. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann NY Acad Sci 1998;851:311-35.
29. Shibasaki T, Imaki T, Hotta M, Ling N, Demura H. Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion. Brain Res 1993;618:71-5.
30. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezigian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998;20:1093-102.
31. Turnbull AV, Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 1997;215:1-10.
32. Wong ML. Licino J, Pasternak KI, Gold PW. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 1994;135:2275-8.
33. Calogero A, Gallucci WT, Gold PW, Chrousos GP. Multiple feedback regulatory loops upon rat hypothalamic corticotropin releasing hormone secretion. J Clin Invest 1988;82:767-74.
34. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
35. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP. Dose-effects of recombinant human interleukin-6 on anterior pituitary hormone secretion and thermogenesis. Neuroendocrinology 1997;66:54-62.
36. Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann NY Acad Sci 1999;876:1-11 (discussion 11-3).
37. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998;129:229-40.
38. Rivier C, Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod 1991;45:523-32.
39. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogen regulation of human corticotropin releasing hormone gene expression: potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J Clin Invest 1993;92:1896-902.
40. Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva F. Dual and selective action of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology 1990;51:51-8.
41. Casanueva FF, Burguera B, Muruais C, Dieguez C. Acute administration of corticosteroids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 1990;70:234-7.
42. Benker G, Raida M, Olbricht T, Wagner R, Reinhardt W, Reinwein D. TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the "the sick euthyroid syndrome". Clin Endocrinol 1990;33:776-86.
43. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuroendocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000;24(Suppl. 2):S50-5.
44. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997;82:4167-70.
45. Tsigos C, Young RJ, White A. Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1993;76:554-8.
46. Gold PW, Chrousos GP. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians 1999;111:22-34.
47. Chikanza IC, Petrou P, Chrousos GP, Kingsley O, Panayi G. Defective hypothalamic response to immune/inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheumatism 1992;35:1281-8.